Financing Health Security Beyond Aid: Building Sovereign Health Systems in BRICS+

Global health financing is undergoing a paradigm shift—and BRICS+ is leading the transition from donor-dependent aid to sovereign, resilient systems. This report delivers a strategic analysis of how BRICS+ nations are redesigning health financing architectures through local currency lending, pooled procurement, and innovative blended finance mechanisms.

Anchored by the New Development Bank (NDB), the bloc is enabling large-scale investments in healthcare infrastructure, digital health ecosystems, and pharmaceutical production while reducing exposure to dollar volatility. The report highlights key initiatives such as social impact bonds, health-for-debt swaps, and AI-driven supply chain financing that enhance efficiency, equity, and long-term sustainability.

It further explores how BRICS+ is leveraging its collective manufacturing strength—producing a majority share of vaccines and active pharmaceutical ingredients—to set global price benchmarks and expand access to essential medicines across emerging markets. Critical challenges such as regulatory fragmentation, financing gaps, and geopolitical risks are also assessed, alongside scenario-based projections for the future of global health governance.

If you are not tracking this financial transformation, you are missing the blueprint for the next global health order. Follow Global Eye Intelligence for expert insights on BRICS+, health financing, global governance, pharmaceutical economics, development finance, and emerging market strategy.